Tolero Pharmaceuticals Inc.
Steven Warner, Ph.D., is Vice President of Discovery and Development at Tolero pharmaceuticals. He specializes in small molecule drug discovery, new screening platforms in drug discovery, and translational research focusing on cancer therapeutics. He is an expert in the discovery of novel cancer agents and has played integral roles in moving multiple compounds into clinical trials. Dr. Warner has a broad background in molecular and cell biology that comes from over a decade of involvement in drug discovery and development in both academic and pharmaceutical industry settings. Dr. Warner earned his graduate degree in Pharmaceutical Sciences at the University of Arizona. He completed a postdoctoral fellowship under the mentoring of Dan Von Hoff at the Translational Genomics Research Institute (TGen). He has held leadership positions in drug development teams, including at SuperGen Inc. and the Huntsman Cancer Institute where his responsibilities ranged from initial compound library screens to proof-of-concept studies in animal models. Dr. Warner worked with the Center for Investigational Therapeutics at the Huntsman Cancer Institute as Senior Manager, Drug Discovery. Together in these capacities, he has led or integrally participated in drug discovery projects that have produced six first-in-man clinical compounds and has published several peer-reviewed publications and patents from multiple drug discovery projects.
Research focusing on cancer therapeutics,discovery of novel cancer agents.